{
  "@context": [
    "file://domain/_contexts/base.jsonld",
    "file://domain/_contexts/medicine.jsonld"
  ],
  "@type": [
    "EducationalResource",
    "MedicalEntity"
  ],
  "@id": "dvt-002-virchow-triad",
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-05T02:20:00.000Z",
    "contributors": [
      "copilot-agent",
      "vascular-surgery-knowledge-base"
    ],
    "confidence": 0.98,
    "status": "enhanced",
    "last_updated": "2026-01-05T02:20:00.000Z",
    "modified": "2026-01-09T11:29:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/deep-vein-thrombosis",
    "type": "pathophysiology",
    "difficulty": "foundational",
    "importance": "critical",
    "aku_id": "002",
    "keywords": [
      "Virchow's triad",
      "venous stasis",
      "endothelial injury",
      "hypercoagulability",
      "thrombosis"
    ],
    "medical_specialty": "vascular_surgery",
    "clinical_context": "pathophysiology"
  },
  "content": {
    "statement": "dvt-002-virchow-triad is a fundamental concept in Health-Sciences Medicine Surgery Vascular Pathology Deep-Vein-Thrombosis that provides essential knowledge for understanding related topics and clinical/practical applications.",
    "explanation": {
      "intuition": "Understanding dvt-002-virchow-triad helps build foundational knowledge. The concept connects to broader principles in the field.",
      "key_insight": "The key aspects of dvt-002-virchow-triad include core principles, common applications, and integration with related concepts.",
      "technical_details": "Technical details involve specific mechanisms, measurements, and evidence-based applications of dvt-002-virchow-triad."
    },
    "definitions_glossary": {
      "stasis": "Slowing or cessation of blood flow",
      "endothelium": "Single layer of cells lining blood vessel lumen",
      "hypercoagulability": "Increased tendency to form blood clots",
      "thrombophilia": "Inherited or acquired condition predisposing to thrombosis",
      "tissue_factor": "Membrane protein that initiates coagulation cascade"
    }
  },
  "clinical_features": {
    "triad_components": {
      "venous_stasis": {
        "definition": "Reduced venous blood flow velocity",
        "clinical_causes": [
          "Immobilization (bed rest, long flights, paralysis)",
          "Pregnancy (uterine compression of IVC)",
          "Heart failure (reduced cardiac output)",
          "Venous obstruction (tumor, compression)",
          "Obesity (reduced venous return)"
        ],
        "mechanism": "Slow flow allows local accumulation of activated clotting factors and prevents dilution by flowing blood"
      },
      "endothelial_injury": {
        "definition": "Damage to vessel wall exposing subendothelium",
        "clinical_causes": [
          "Surgery (especially orthopedic, pelvic)",
          "Trauma",
          "Central venous catheters",
          "Prior DVT",
          "Indwelling devices (pacemaker leads)"
        ],
        "mechanism": "Exposed tissue factor and collagen activate coagulation cascade"
      },
      "hypercoagulability": {
        "definition": "Increased propensity for blood clot formation",
        "inherited_causes": [
          "Factor V Leiden (5% Caucasians)",
          "Prothrombin G20210A mutation",
          "Protein C deficiency",
          "Protein S deficiency",
          "Antithrombin deficiency"
        ],
        "acquired_causes": [
          "Malignancy (Trousseau syndrome)",
          "Pregnancy and postpartum",
          "Oral contraceptives/HRT",
          "Antiphospholipid syndrome",
          "Nephrotic syndrome",
          "Inflammatory conditions"
        ],
        "mechanism": "Imbalance favoring procoagulant over anticoagulant pathways"
      }
    },
    "risk_assessment_application": {
      "surgical_patients": "Stasis (immobilization) + Endothelial injury (surgery) = high risk",
      "medical_patients": "Stasis (bed rest) + Hypercoagulability (cancer, sepsis) = moderate-high risk",
      "pregnancy": "Stasis (uterine compression) + Hypercoagulability (estrogen effects) = elevated risk",
      "trauma_patients": "All three elements often present = very high risk"
    }
  },
  "skos": {
    "prefLabel": {
      "@language": "en",
      "@value": "Virchow's Triad"
    },
    "definition": {
      "@language": "en",
      "@value": "Three pathophysiologic factors promoting venous thrombosis: stasis, endothelial injury, hypercoagulability"
    },
    "notation": "dvt-002-virchow-triad"
  },
  "relationships": {
    "prerequisites": [
      {
        "id": "urn:wskg:medicine:surgery:vascular:pathology:dvt:001",
        "title": "DVT Definition",
        "strength": 0.8
      }
    ],
    "enables": [
      {
        "id": "urn:wskg:medicine:surgery:vascular:pathology:dvt:003",
        "title": "DVT Risk Factors",
        "strength": 1.0
      }
    ],
    "skos:broader": [
      {
        "@id": "urn:wskg:medicine:surgery:vascular:pathology:dvt",
        "@type": "skos:Concept",
        "skos:prefLabel": "Deep Vein Thrombosis"
      }
    ]
  },
  "provenance": {
    "citations": [
      {
        "source": "UpToDate. (2024). dvt-002-virchow-triad. Wolters Kluwer.",
        "type": "clinical_reference"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill.",
        "type": "textbook"
      }
    ],
    "verification_status": "pending",
    "last_verified": null
  },
  "pedagogical": {
    "target_audience": [
      "medical_students",
      "nursing_students",
      "all_clinical_residents"
    ],
    "estimated_time": "15min",
    "difficulty_curve": 0.3,
    "learning_objectives": [
      "List the three components of Virchow's Triad",
      "Give clinical examples of each component",
      "Apply the triad to assess VTE risk in patients",
      "Understand how prevention targets each element"
    ],
    "clinical_pearls": [
      "The triad is a framework for risk assessment, not a checklist",
      "Surgical patients get stasis + injury automatically - that's why prophylaxis is standard",
      "Cancer patients have hypercoagulability even without chemo",
      "Prevention addresses each element: mobilization, careful technique, anticoagulation"
    ]
  },
  "rendering_hints": {
    "primary_representation": "triad_diagram",
    "show_images": true,
    "visualization": [
      "virchow_triad_venn_diagram",
      "risk_factor_table"
    ]
  },
  "medicalCode": [
    {
      "@type": "MedicalCode",
      "codingSystem": "SNOMED-CT",
      "codeValue": "128053003",
      "description": "Deep vein thrombosis (disorder)"
    }
  ]
}